Catasys Inc (NASDAQ:CATS) Director Michael Edward Sherman purchased 15,550 shares of the firm’s stock in a transaction on Tuesday, March 13th. The shares were purchased at an average cost of $4.79 per share, with a total value of $74,484.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Shares of NASDAQ CATS opened at $4.68 on Friday. Catasys Inc has a 1 year low of $3.30 and a 1 year high of $14.00.
Catasys (NASDAQ:CATS) last issued its quarterly earnings results on Wednesday, March 7th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.08). The business had revenue of $3.04 million during the quarter, compared to analysts’ expectations of $3.00 million. research analysts predict that Catasys Inc will post -0.58 earnings per share for the current fiscal year.
Separately, Zacks Investment Research raised Catasys from a “sell” rating to a “hold” rating in a research note on Thursday, February 8th.
A hedge fund recently bought a new stake in Catasys stock. Weber Alan W acquired a new position in shares of Catasys Inc (NASDAQ:CATS) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 108,165 shares of the company’s stock, valued at approximately $406,000. Weber Alan W owned approximately 0.68% of Catasys as of its most recent SEC filing. Institutional investors and hedge funds own 4.67% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Insider Buying: Catasys Inc (CATS) Director Purchases 15,550 Shares of Stock” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/04/08/catasys-inc-cats-director-michael-edward-sherman-purchases-15550-shares.html.
Catasys, Inc provides data analytics based specialized behavioral health management and integrated treatment services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services. The company's OnTrak solution includes medical and psychosocial interventions; and a proprietary Web based clinical information platform and database, psychosocial programs, and integrated care coaching services.
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.